Downregulation of MicroRNA-19b contributes to angiotensin II-induced overexpression of connective tissue growth factor in cardiomyocytes

Cardiology (Switzerland)

Volumn 127, Issue 2, 2014, Pages 114-120

  Gao, Song ^a   Liu, Tie Wen ^b   Wang, Zhe ^c   Jiao, Zhen Yu ^c   Cai, Jun ^c   Chi, Hong Jie ^c,d   Yang, Xin Chun ^c  

^a TEXAS HEART INSTITUTE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin II; Cardiomyocytes; Connective tissue growth factor; MicroRNA

Indexed keywords

ANGIOTENSIN II; CONNECTIVE TISSUE GROWTH FACTOR; MICRORNA; MICRORNA 19B; TELMISARTAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSFECTION; HEART CELL CULTURE; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; CELL ISOLATION; DRUG MECHANISM; GENE OVEREXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; CONNECTIVE TISSUE GROWTH FACTOR; DOWN-REGULATION; MICRORNAS; MYOCYTES, CARDIAC; RATS; RNA, MESSENGER; UP-REGULATION;

EID: 84893239575     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000355429     Document Type: Article

References (35)

1. Jessup M, Brozena S: Heart failure. N Engl J Med 2003; 348: 2007-2018.
2. Swynghedauw B: Molecular mechanisms of myocardial remodeling. Physiol Rev 1999; 79: 215-262.
3. Koitabashi N, Arai M, Kogure S, Niwano K, Watanabe A, Aoki Y, Maeno T, Nishida T, Kubota S, Takigawa M, Kurabayashi M: Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis. Hypertension 2007; 49: 1120-1127.
4. Tsoutsman T, Wang X, Garchow K, Riser B, Twigg S, Semsarian C: CCN2 plays a key role in extracellular matrix gene expression in severe hypertrophic cardiomyopathy and heart failure. J Mol Cell Cardiol 2013; 62: 164-178.
5. Chen MM, Lam A, Abraham JA, Schreiner GF, Joly AH: CTGF expression is induced by TGF-beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol 2000; 32: 1805-1819.
6. Finckenberg P, Inkinen K, Ahonen J, Merasto S, Louhelainen M, Vapaatalo H, Muller D, Ganten D, Luft F, Mervaala E: Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways. Am J Pathol 2003; 163: 355-366.
7. Perbal B: CCN proteins: multifunctional signalling regulators. Lancet 2004; 363: 62-64.
8. Bork P: The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 1993; 327: 125-130.
9. Blom IE, Goldschmeding R, Leask A: Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy? Matrix Biol 2002; 21: 473-482.
10. Ahmed MS, Oie E, Vinge LE, Yndestad A, Oystein Andersen G, Andersson Y, Attramadal T, Attramadal H: Connective tissue growth factor - a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats. J Mol Cell Cardiol 2004; 36: 393-404.
11. Sopel MJ, Rosin NL, Falkenham AG, Bezuhly M, Esmon CT, Lee TD, Liwski RS, Legare JF: Treatment with activated protein C (aPC) is protective during the development of myocardial fibrosis: an angiotensin II infusion model in mice. PLoS One 2012; 7:e45663.
12. Matsui Y, Sadoshima J: Rapid upregulation of CTGF in cardiac myocytes by hypertrophic stimuli: implication for cardiac fibrosis and hypertrophy. J Mol Cell Cardiol 2004; 37: 477- 481.
13. He Z, Way KJ, Arikawa E, Chou E, Opland DM, Clermont A, Isshiki K, Ma RC, Scott JA, Schoen FJ, Feener EP, King GL: Differential regulation of angiotensin II-induced expression of connective tissue growth factor by protein kinase C isoforms in the myocardium. J Biol Chem 2005; 280: 15719-15726.
14. Ambros V: microRNAs: tiny regulators with great potential. Cell 2001; 107: 823-826.
15. Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, Allen PD, Golub TR, Pieske B, Pu WT: Altered microRNA expression in human heart disease. Physiol Genomics 2007; 31: 367-373.
16. van Almen GC, Verhesen W, van Leeuwen RE, van de Vrie M, Eurlings C, Schellings MW, Swinnen M, Cleutjens JP, van Zandvoort MA, Heymans S, Schroen B: MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure. Aging Cell 2011; 10: 769-779.
17. Chou E, Suzuma I, Way KJ, Opland D, Clermont AC, Naruse K, Suzuma K, Bowling NL, Vlahos CJ, Aiello LP, King GL: Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic states: a possible explanation for impaired collateral formation in cardiac tissue. Circulation 2002; 105: 373-379.
18. Wakasaki H, Koya D, Schoen FJ, Jirousek MR, Ways DK, Hoit BD, Walsh RA, King GL: Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy. Proc Natl Acad Sci USA 1997; 94: 9320-9325.
19. Kim S, Iwao H: Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 2000; 52: 11-34.
20. Billet S, Aguilar F, Baudry C, Clauser E: Role of angiotensin II AT1 receptor activation in cardiovascular diseases. Kidney Int 2008; 74: 1379-1384.
21. Wei LH, Huang XR, Zhang Y, Li YQ, Chen HY, Yan BP, Yu CM, Lan HY: Smad7 inhibits angiotensin II-induced hypertensive cardiac remodeling. Cardiovasc Res 2013; 99: 665-673.
22. Li HL, She ZG, Li TB, Wang AB, Yang Q, Wei YS, Wang YG, Liu DP: Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice. Hypertension 2007; 49: 1399-1408.
23. Liu J, Yang F, Yang XP, Jankowski M, Pagano PJ: NAD(P)H oxidase mediates angiotensin II-induced vascular macrophage infiltration and medial hypertrophy. Arterioscler Thromb Vasc Biol 2003; 23: 776-782.
24. Sopel M, Falkenham A, Oxner A, Ma I, Lee TD, Legare JF: Fibroblast progenitor cells are recruited into the myocardium prior to the development of myocardial fibrosis. Int J Exp Pathol 2012; 93: 115-124.
25. Moussad EE, Brigstock DR: Connective tissue growth factor: what's in a name? Mol Genet Metab 2000; 71: 276-292.
26. Shi-Wen X, Leask A, Abraham D: Regulation and function of connective tissue growth factor/ CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev 2008; 19: 133-144.
27. Touvron M, Escoubet B, Mericskay M, Angelini A, Lamotte L, Santini MP, Rosenthal N, Daegelen D, Tuil D, Decaux JF: Locally expressed IGF1 propeptide improves mouse heart function in induced dilated cardiomyopathy by blocking myocardial fibrosis and SRF-dependent CTGF induction. Dis Model Mech 2012; 5: 481-491.
28. Frangogiannis NG, Ren G, Dewald O, Zymek P, Haudek S, Koerting A, Winkelmann K, Michael LH, Lawler J, Entman ML: Critical role of endogenous thrombospondin- 1 in preventing expansion of healing myocardial infarcts. Circulation 2005; 111: 2935-2942.
29. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB: Prediction of mammalian microRNA targets. Cell 2003; 115: 787-798.
30. Brennecke J, Stark A, Russell RB, Cohen SM: Principles of microRNA-target recognition. PLoS Biol 2005; 3:e85.
31. Jackson RJ, Standart N: How do microRNAs regulate gene expression? Sci STKE 2007; 2007:re1.
32. Nilsen TW: Mechanisms of microRNA-mediated gene regulation in animal cells. Trends Genet 2007; 23: 243-249.
33. He L, Thomson JM, Hemann MT, Hernando- Monge E, Mu D, Goodson S, Powers S, Cordon- Cardo C, Lowe SW, Hannon GJ, Hammond SM: A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828-833.
34. Lakner AM, Steuerwald NM, Walling TL, Ghosh S, Li T, McKillop IH, Russo MW, Bonkovsky HL, Schrum LW: Inhibitory effects of microRNA 19b in hepatic stellate cellmediated fibrogenesis. Hepatology 2012; 56: 300-310.
35. Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D, Stone JR, Jaenisch R, Sharp PA, Jacks T: Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 2008; 132: 875-886.